OriGene Buys SDIX's Life Science Assets for $16 Million
NEW YORK (GenomeWeb News) – OriGene Technologies and SDIX today announced a definitive agreement for OriGene to buy the Life Science assets of SDIX for $16 million.
In Brief This Week: Eppendorf; SDIX; EMD Millipore; Addgene, MJFF
NEW YORK (GenomeWeb News) – Eppendorf this week opened its new UK headquarters in the Arlington Business Park in Stevenage.
Soft Biopharma Sales Contribute to 10 Percent Drop in SDIX Q2 Revenues
NEW YORK (GenomeWeb News) – SDIX reported after the close of the market on Wednesday that its second-quarter revenues fell 10 percent year over year.
SDIX's Q1 Revenues Slide 15 Percent
NEW YORK (GenomeWeb News) – SDIX reported after the close of the market on Thursday a 15 percent falloff year over year in first-quarter revenues. The company also announced a deal with a top-10 drug firm to generate monoclonal antibodies against a GPCR target.
SDIX's Q4 Revenues Shrink 13 Percent
NEW YORK (GenomeWeb News) – SDIX today reported that its fourth-quarter revenues dipped 13 percent year over year, as its Life Science business dropped 11 percent.
Nov 14, 2011
SDIX Q3 Revenues Slide 8 Percent
Jul 28, 2011
SDIX's Q2 Revenues Rise 4 Percent
May 13, 2011
SDIX Posts 12 Percent Q1 Revenue Growth
May 4, 2010
SDIX's Q1 Revenues Dip
Feb 25, 2010